85.05MMarket Cap14.50P/E (TTM)
1.160High1.140Low104.17KVolume1.150Open1.150Pre Close119.96KTurnover0.19%Turnover Ratio12.89P/E (Static)73.32MShares2.09052wk High2.86P/B63.25MFloat Cap1.02052wk Low--Dividend TTM54.52MShs Float1037.500Historical High--Div YieldTTM1.74%Amplitude0.700Historical Low1.151Avg Price1Lot Size
Protalix Biotherapeutics Stock Forum
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical firm, will host an in-person investor day on June 26, 2024, at the Lotte Palace New York Hotel. The event will begin at 8:30 a.m. EDT. Key opinion leaders, including Aleš Linhart of Charles University and Naomi Schlesinger of the Univers...
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical company specializing in recombinant therapeutic proteins via its ProCellEx® plant cell-based system, announced its participation at the 2024 BIO International Convention in San Diego, California. The convention, hosted by the Biotechnology Innovation Organization (BIO), is the largest industry event, gathering glo...
positive EMA to be anounced. Possibly as early as tommorow
Here are the notable stocks with the highest and lowest implied volatility.
The $First Republic Bank(FRC.US)$, $ImmunoGen(IMGN.US)$, and $Protalix Biotherapeutics(PLX.US)$has the highest implied volatility of all s...
No comment yet